TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$48.19M2012: -$59.59M2013: -$127.07M2014: $104.08M2015: $131.00M2016: $68.12M2017: $122.57M2018: $635.93M2019: $392.88M2020: $244.35M2021: $74.01M2022: $5.23M2023: -$30.58M2024: -$49.19M2025: $32.61M$32.61M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$32.61M+166.3%
2024-$49.19M-60.8%
2023-$30.58M-684.8%
2022$5.23M-92.9%
2021$74.01M-69.7%
2020$244.35M-37.8%
2019$392.88M-38.2%
2018$635.93M+418.8%
2017$122.57M+79.9%
2016$68.12M-48.0%
2015$131.00M+25.9%
2014$104.08M+181.9%
2013-$127.07M-113.3%
2012-$59.59M-23.6%
2011-$48.19M—